The Department of Agriculture is targeting a rollout of the African swine fever vaccine within this year, pending approval from the Food and Drug Administration.
This initiative is poised to bring significant relief to the country’s swine industry, which has been severely impacted by African swine fever.
Preparing for FDA Approval
Agriculture Secretary Francisco Tiu Laurel Jr. recently disclosed that Food and Drug Administration approval for the trial of African swine fever vaccines from Vietnam is expected within two weeks.
“Controlled vaccinations to be monitored by BAI and FDA will commence in two weeks,” Laurel mentioned in a phone interview.
This approval is critical to ensure the safe and effective implementation of the vaccine.
- Controlled Trials: The trial vaccinations will involve selected hogs to ensure any potential risks are closely monitored.
- Significant Progress: This step is a considerable advancement from previous laboratory trials with small sample sizes.
- Collaboration: The Bureau of Animal Industry and Food and Drug Administration will jointly monitor these vaccinations.
Enhancing Industrial Growth and Competitiveness
The DA’s Assistant Secretary, Arnel de Mesa, highlighted the expectation that once the vaccine is approved within the year, African swine fever will no longer be a significant issue by next year.
“Our expectation is for it to be approved within the year so next year, we will no longer have a problem with ASF,”
de Mesa stated during an ambush interview at the sidelines of a large-scale trial of the P29 Project in Marikina City.
Additional Measures
Besides the African swine fever vaccination, the Department of Agriculture is implementing more stringent border measures to combat similar threats, including bird flu and Q fever.
One such measure is the operation of Cold Examination Facilities for Agriculture. These facilities will serve as sanitary phytosanitary inspection centers for imported animals, fish, plants, and other agricultural products.
Planned CEFA Sites
- Angat, Bulacan: Expected to be operational by January 2025.
- Subic, Manila, Davao, General Santos City: Additional sites planned to enhance biosecurity measures.
Future Plans
The rollout of the African swine fever vaccine represents a significant step in controlling the spread of the disease in the Philippines. The vaccine, sourced from Vietnam, has shown high effectiveness. In 2023, Vietnam exported two million vaccine doses to the Philippines after approving domestic use of the world’s first commercial ASF vaccines.
- Commercial Distribution: Following successful trials, the vaccine is expected to be available for commercial distribution.
- End of African Swine Fever: The DA anticipates that by next year (2025), African swine fever will no longer pose a significant threat to the country’s swine industry.
Final Summary
This collaboration between the Department of Agriculture and FDA, alongside stringent biosecurity measures, demonstrates a comprehensive approach to combating African swine fever and other agricultural threats.
The upcoming vaccine rollout is a beacon of hope for the Philippine swine industry, promising to restore stability and growth.
Sources: THX News & Philippine News Agency.
